Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral β-amyloidosis
Abstract Cerebral β-amyloidosis is a major feature of Alzheimer’s disease (AD), characterized by the accumulation of β-amyloid protein (Aβ) in the brain. Several studies have implicated lipid/lipoprotein metabolism in the regulation of β-amyloidosis. In this regard, HDL (High Density Lipoprotein)-ba...
Main Authors: | Sofía Fernández-de-Retana, Mary Cano-Sarabia, Paula Marazuela, Jose Luis Sánchez-Quesada, Annabel Garcia-Leon, Alex Montañola, Joan Montaner, Daniel Maspoch, Mar Hernández-Guillamon |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-15215-w |
Similar Items
-
The effect of reconstituted high density lipoprotein (rHDL) infusion on patients with symptomatic carotid disease
by: Nasr, Hosaam Hassan
Published: (2013) -
Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice
by: Sofía Fernández de Retana, et al.
Published: (2019-05-01) -
Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome.
by: Catherine Gebhard, et al.
Published: (2017-01-01) -
Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice
by: Emily E. Morin, et al.
Published: (2020-12-01) -
Pre-clinical evaluation of rHDL encapsulated retinoids for the treatment of Neuroblastoma
by: Nirupama eSabnis, et al.
Published: (2013-03-01)